NCT01658618View on ClinicalTrials.gov

Safety Study Providing 12 Months Follow-up From First Exposure to HP802-247 in Subjects With Venous Leg Ulcer

UnknownOBSERVATIONAL
Enrollment

440

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

March 31, 2015

Study Completion Date

May 31, 2015

Conditions
Venous Leg Ulcer
Interventions
BIOLOGICAL

HP802-247

Trial Locations (49)

10025

New York

18512

Dunmore

19610

Wyomissing

20007

Washington D.C.

21224

Baltimore

24013

Roanoke

27599

Chapel Hill

32605

Gainesville

33013

Hialeah

33125

Miami

33143

South Miami

33321

Tamarac

44307

Akron

60064

North Chicago

60611

Chicago

60612

Chicago

60616

Chicago

62650

Jacksonville

62702

Springfield

74127

Tulsa

75390

Dallas

76104

Fort Worth

76107

Fort Worth

78229

San Antonio

84770

St. George

85006

Phoenix

85012

Phoenix

85306

Glendale

85723

Tucson

85724

Tucson

89119

Las Vegas

90095

Los Angeles

90822

Long Beach

91342

Sylmar

92009

Carlsbad

92013

San Diego

92653

Laguna Hills

94115

San Francisco

94546

Castro Valley

95204

Stockton

98431

Tacoma

02118

Boston

02138

Cambridge

07630

Emerson

V5Z1M9

Vancouver

P3E5J1

Greater Sudbury

L8R2R3

Hamilton

N6C5J1

London

J1H5N4

Sherbrooke

Sponsors

Lead Sponsor

Healthpoint
All Listed Sponsors
lead

Healthpoint

INDUSTRY